Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone H3K4 monomethyltransferase activity

KMT2A KMT2B

2.39e-058192GO:0140945
GeneOntologyMolecularFunctionunmethylated CpG binding

KMT2A KMT2B

3.84e-0510192GO:0045322
GeneOntologyMolecularFunctionhistone H3K4 trimethyltransferase activity

KMT2A KMT2B

3.84e-0510192GO:0140999
GeneOntologyMolecularFunctionphosphatidylinositol-3,5-bisphosphate 3-phosphatase activity

MTMR3 MTMR4

4.69e-0511192GO:0052629
GeneOntologyMolecularFunctionphosphatidylinositol-3-phosphate phosphatase activity

MTMR3 MTMR4

7.75e-0514192GO:0004438
GeneOntologyMolecularFunctionphosphatidylinositol monophosphate phosphatase activity

MTMR3 MTMR4

8.94e-0515192GO:0052744
GeneOntologyMolecularFunctionphosphatidylinositol-3,5-bisphosphate phosphatase activity

MTMR3 MTMR4

1.02e-0416192GO:0106018
GeneOntologyMolecularFunction1-phosphatidylinositol binding

WDFY3 EEA1

1.16e-0417192GO:0005545
GeneOntologyMolecularFunctionphospholipid binding

SYT8 ZFYVE28 RUBCNL WDFY3 EEA1

1.29e-04548195GO:0005543
GeneOntologyMolecularFunctionhistone H3K4 methyltransferase activity

KMT2A KMT2B

1.61e-0420192GO:0042800
GeneOntologyMolecularFunctionphosphatidylinositol binding

ZFYVE28 RUBCNL WDFY3 EEA1

1.98e-04316194GO:0035091
GeneOntologyMolecularFunctionlipid binding

SYT8 ZFYVE28 RASGRP4 RUBCNL WDFY3 EEA1

2.25e-04988196GO:0008289
GeneOntologyMolecularFunctionphosphatidylinositol bisphosphate phosphatase activity

MTMR3 MTMR4

2.97e-0427192GO:0034593
GeneOntologyMolecularFunctionphosphatidylinositol phosphate phosphatase activity

MTMR3 MTMR4

3.67e-0430192GO:0052866
GeneOntologyMolecularFunctionhistone H3 methyltransferase activity

KMT2A KMT2B

7.92e-0444192GO:0140938
GeneOntologyMolecularFunctionphosphatidylinositol-3-phosphate binding

ZFYVE28 RUBCNL

9.43e-0448192GO:0032266
GeneOntologyMolecularFunctionguanyl-nucleotide exchange factor activity

FGD6 RASGRP4 FGD5

1.29e-03231193GO:0005085
GeneOntologyMolecularFunctionprotein-lysine N-methyltransferase activity

KMT2A KMT2B

1.88e-0368192GO:0016279
GeneOntologyMolecularFunctionlysine N-methyltransferase activity

KMT2A KMT2B

1.94e-0369192GO:0016278
GeneOntologyMolecularFunctionhistone methyltransferase activity

KMT2A KMT2B

2.05e-0371192GO:0042054
GeneOntologyMolecularFunctionprotein methyltransferase activity

KMT2A KMT2B

4.26e-03103192GO:0008276
GeneOntologyMolecularFunctionprotein tyrosine phosphatase activity

MTMR3 MTMR4

4.26e-03103192GO:0004725
GeneOntologyMolecularFunctionN-methyltransferase activity

KMT2A KMT2B

4.42e-03105192GO:0008170
GeneOntologyMolecularFunctionprotein serine/threonine phosphatase activity

MTMR3 MTMR4

4.75e-03109192GO:0004722
GeneOntologyMolecularFunctioncalcium ion binding

MEGF6 SYT8 RASGRP4 FBLN1

4.85e-03749194GO:0005509
GeneOntologyMolecularFunctionzinc ion binding

TRIM45 KMT2A EEA1 KMT2B

8.92e-03891194GO:0008270
GeneOntologyMolecularFunctionS-adenosylmethionine-dependent methyltransferase activity

KMT2A KMT2B

1.15e-02172192GO:0008757
GeneOntologyMolecularFunctionGTPase regulator activity

FGD6 RASGRP4 FGD5

1.16e-02507193GO:0030695
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

FGD6 RASGRP4 FGD5

1.16e-02507193GO:0060589
GeneOntologyMolecularFunctionphosphoprotein phosphatase activity

MTMR3 MTMR4

1.37e-02189192GO:0004721
GeneOntologyMolecularFunctionphosphatidylinositol phosphate binding

ZFYVE28 RUBCNL

1.51e-02199192GO:1901981
GeneOntologyMolecularFunctionprotein phosphatase binding

MTMR3 MTMR4

1.67e-02210192GO:0019903
GeneOntologyMolecularFunctionmethyltransferase activity

KMT2A KMT2B

1.72e-02213192GO:0008168
GeneOntologyMolecularFunctiontransferase activity, transferring one-carbon groups

KMT2A KMT2B

1.89e-02224192GO:0016741
GeneOntologyMolecularFunctionhistone modifying activity

KMT2A KMT2B

1.97e-02229192GO:0140993
GeneOntologyBiologicalProcessregulation of phosphatidylinositol dephosphorylation

MTMR3 MTMR4

1.20e-056192GO:0060304
GeneOntologyCellularComponentMLL1/2 complex

KMT2A KMT2B

4.06e-0433192GO:0044665
GeneOntologyCellularComponentearly endosome

ZFYVE28 FGD5 MTMR4 EEA1

8.15e-04481194GO:0005769
GeneOntologyCellularComponentearly endosome membrane

ZFYVE28 MTMR4 EEA1

8.84e-04212193GO:0031901
GeneOntologyCellularComponentautophagosome membrane

RUBCNL WDFY3

1.21e-0357192GO:0000421
GeneOntologyCellularComponenthistone methyltransferase complex

KMT2A KMT2B

2.09e-0375192GO:0035097
GeneOntologyCellularComponentendosome

ZFYVE28 FGD5 MTMR4 EEA1 ZFYVE21

3.24e-031167195GO:0005768
GeneOntologyCellularComponentmethyltransferase complex

KMT2A KMT2B

4.27e-03108192GO:0034708
GeneOntologyCellularComponentautophagosome

RUBCNL WDFY3

5.16e-03119192GO:0005776
DomainFYVE

MTMR3 ZFYVE28 FGD6 FGD5 MTMR4 WDFY3 EEA1 ZFYVE21

8.75e-1929198PF01363
DomainFYVE

MTMR3 ZFYVE28 FGD6 FGD5 MTMR4 WDFY3 EEA1 ZFYVE21

8.75e-1929198SM00064
DomainZnf_FYVE-rel

MTMR3 ZFYVE28 FGD6 FGD5 MTMR4 WDFY3 EEA1 ZFYVE21

3.69e-1834198IPR017455
DomainZnf_FYVE

MTMR3 ZFYVE28 FGD6 FGD5 MTMR4 WDFY3 EEA1 ZFYVE21

9.92e-1838198IPR000306
DomainZF_FYVE

MTMR3 ZFYVE28 FGD6 FGD5 MTMR4 WDFY3 EEA1 ZFYVE21

1.56e-1740198PS50178
DomainZnf_FYVE_PHD

MTMR3 ZFYVE28 KMT2A FGD6 FGD5 MTMR4 WDFY3 EEA1 KMT2B ZFYVE21

5.82e-171471910IPR011011
Domain-

MTMR3 ZFYVE28 TRIM45 KMT2A FGD6 FGD5 MTMR4 WDFY3 EEA1 KMT2B ZFYVE21

8.73e-1444919113.30.40.10
DomainZnf_RING/FYVE/PHD

MTMR3 ZFYVE28 TRIM45 KMT2A FGD6 FGD5 MTMR4 WDFY3 EEA1 KMT2B ZFYVE21

1.11e-134591911IPR013083
DomainMeTrfase_trithorax

KMT2A KMT2B

9.80e-072192IPR016569
DomainFYrich_C

KMT2A KMT2B

9.79e-065192IPR003889
DomainFYrich_N

KMT2A KMT2B

9.79e-065192IPR003888
DomainFYRC

KMT2A KMT2B

9.79e-065192SM00542
DomainFYRN

KMT2A KMT2B

9.79e-065192SM00541
DomainFYRN

KMT2A KMT2B

9.79e-065192PF05964
DomainFYRC

KMT2A KMT2B

9.79e-065192PF05965
DomainFYRC

KMT2A KMT2B

9.79e-065192PS51543
DomainFYRN

KMT2A KMT2B

9.79e-065192PS51542
Domainzf-CXXC

KMT2A KMT2B

5.36e-0511192PF02008
DomainZnf_CXXC

KMT2A KMT2B

5.36e-0511192IPR002857
DomainZF_CXXC

KMT2A KMT2B

5.36e-0511192PS51058
DomainPH_dom-like

MTMR3 FGD6 FGD5 MTMR4 WDFY3

5.38e-05426195IPR011993
DomainPPASE_MYOTUBULARIN

MTMR3 MTMR4

8.86e-0514192PS51339
DomainMyotubularin_fam

MTMR3 MTMR4

8.86e-0514192IPR030564
DomainMyotub-related

MTMR3 MTMR4

8.86e-0514192PF06602
DomainMyotubularin-like_Pase_dom

MTMR3 MTMR4

8.86e-0514192IPR010569
DomainPost-SET_dom

KMT2A KMT2B

1.17e-0416192IPR003616
DomainPostSET

KMT2A KMT2B

1.17e-0416192SM00508
DomainPOST_SET

KMT2A KMT2B

1.17e-0416192PS50868
DomainEPHD

KMT2A KMT2B

2.24e-0422192PS51805
DomainAT_hook

KMT2A KMT2B

3.39e-0427192SM00384
DomainAT_hook_DNA-bd_motif

KMT2A KMT2B

3.39e-0427192IPR017956
Domain-

MTMR3 FGD6 FGD5 MTMR4

5.71e-043911942.30.29.30
DomainSET

KMT2A KMT2B

7.85e-0441192PF00856
DomainSET

KMT2A KMT2B

9.88e-0446192SM00317
DomainSET_dom

KMT2A KMT2B

1.17e-0350192IPR001214
DomainSET

KMT2A KMT2B

1.17e-0350192PS50280
DomainRhoGEF

FGD6 FGD5

2.15e-0368192SM00325
DomainDH_2

FGD6 FGD5

2.27e-0370192PS50010
DomainRhoGEF

FGD6 FGD5

2.27e-0370192PF00621
DomainDH-domain

FGD6 FGD5

2.34e-0371192IPR000219
Domain-

FGD6 FGD5

2.34e-03711921.20.900.10
DomainTyr_Pase_AS

MTMR3 MTMR4

2.47e-0373192IPR016130
DomainPHD

KMT2A KMT2B

2.60e-0375192PF00628
DomainZnf_PHD-finger

KMT2A KMT2B

2.88e-0379192IPR019787
DomainTYR_PHOSPHATASE_1

MTMR3 MTMR4

3.41e-0386192PS00383
DomainEGF_CA

MEGF6 FBLN1

3.41e-0386192PF07645
DomainTYR_PHOSPHATASE_2

MTMR3 MTMR4

3.48e-0387192PS50056
DomainTYR_PHOSPHATASE_dom

MTMR3 MTMR4

3.48e-0387192IPR000387
DomainPHD

KMT2A KMT2B

3.64e-0389192SM00249
DomainZnf_PHD

KMT2A KMT2B

3.80e-0391192IPR001965
Domain-

MTMR3 MTMR4

3.89e-03921923.90.190.10
DomainZF_PHD_2

KMT2A KMT2B

4.14e-0395192PS50016
DomainZF_PHD_1

KMT2A KMT2B

4.22e-0396192PS01359
DomainEGF_Ca-bd_CS

MEGF6 FBLN1

4.31e-0397192IPR018097
DomainEGF_CA

MEGF6 FBLN1

4.48e-0399192PS01187
DomainProt-tyrosine_phosphatase-like

MTMR3 MTMR4

4.48e-0399192IPR029021
DomainASX_HYDROXYL

MEGF6 FBLN1

4.57e-03100192PS00010
DomainEGF-type_Asp/Asn_hydroxyl_site

MEGF6 FBLN1

5.12e-03106192IPR000152
DomainEGF_CA

MEGF6 FBLN1

6.73e-03122192SM00179
DomainEGF-like_Ca-bd_dom

MEGF6 FBLN1

6.94e-03124192IPR001881
DomainGrowth_fac_rcpt_

MEGF6 FBLN1

1.08e-02156192IPR009030
PathwayREACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES

KMT2A KMT2B

8.29e-0438162MM17073
PathwayREACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES

KMT2A KMT2B

1.01e-0342162M48018
PathwayREACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION

KMT2A KMT2B

1.11e-0344162MM15527
PathwayREACTOME_PKMTS_METHYLATE_HISTONE_LYSINES

KMT2A KMT2B

1.21e-0346162MM14933
PathwayWP_PHOSPHOINOSITIDES_METABOLISM

MTMR3 MTMR4

1.38e-0349162M40046
PathwayWP_HISTONE_MODIFICATIONS

KMT2A KMT2B

2.41e-0365162M39374
PathwayREACTOME_PKMTS_METHYLATE_HISTONE_LYSINES

KMT2A KMT2B

2.79e-0370162M27231
PathwayREACTOME_PI_METABOLISM

MTMR3 MTMR4

3.36e-0377162MM14590
Pubmed

KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions.

KMT2A KMT2B

2.83e-07219228723559
Pubmed

FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphotidylinositol 3-phosphate.

MTMR3 MTMR4

8.48e-07319211302699
Pubmed

PtdIns3P phosphatases MTMR3 and MTMR4 negatively regulate innate immune responses to DNA through modulating STING trafficking.

MTMR3 MTMR4

8.48e-07319230944173
Pubmed

WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket.

KMT2A KMT2B

1.70e-06419218840606
Pubmed

MLL1 is required for PAX7 expression and satellite cell self-renewal in mice.

KMT2A KMT2B

1.70e-06419231534153
Pubmed

A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.

KMT2A KMT2B

1.70e-06419223129768
Pubmed

Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation.

KMT2A KMT2B

1.70e-06419217166833
Pubmed

Aven recognition of RNA G-quadruplexes regulates translation of the mixed lineage leukemia protooncogenes.

KMT2A KMT2B

1.70e-06419226267306
Pubmed

Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory.

KMT2A KMT2B

1.70e-06419225834037
Pubmed

Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA.

KMT2A KMT2B

1.70e-06419234156981
Pubmed

The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity.

MTMR3 MTMR4

2.82e-06519226787466
Pubmed

Evolving Catalytic Properties of the MLL Family SET Domain.

KMT2A KMT2B

2.82e-06519226320581
Pubmed

Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.

KMT2A KMT2B

2.82e-06519225561738
Pubmed

MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.

KMT2A KMT2B

2.82e-06519228609655
Pubmed

MLL associates specifically with a subset of transcriptionally active target genes.

KMT2A KMT2B

4.24e-06619216199523
Pubmed

Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs.

KMT2A KMT2B

4.24e-06619224176642
Pubmed

Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.

KMT2A KMT2B

7.90e-06819223130995
Pubmed

The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.

KMT2A KMT2B

7.90e-06819222266653
Pubmed

Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.

KMT2A KMT2B

1.02e-05919216951254
Pubmed

Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.

MEGF6 FBLN1

1.02e-05919212122015
Pubmed

Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.

KMT2A KMT2B

1.02e-05919222665483
Pubmed

DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants.

KMT2A KMT2B

1.27e-051019229276034
Pubmed

Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human.

MTMR3 MTMR4

1.27e-05101929736772
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MTMR4 WDFY3 KMT2B

1.42e-058719312465718
Pubmed

Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions.

MTMR3 MTMR4

1.86e-051219216787938
Pubmed

Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.

KMT2A KMT2B

1.86e-051219227563068
Pubmed

Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.

KMT2A KMT2B

2.20e-051319224619213
Pubmed

A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity.

FHL3 KMT2A

2.96e-051519228094252
Pubmed

SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.

KMT2A KMT2B

3.38e-051619223870121
Pubmed

Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.

KMT2A KMT2B

5.90e-052119227626377
Pubmed

Structural basis for activity regulation of MLL family methyltransferases.

KMT2A KMT2B

6.49e-052219226886794
Pubmed

Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.

KMT2A KMT2B

8.42e-052519225664857
Pubmed

Rebalancing gene haploinsufficiency in vivo by targeting chromatin.

KMT2A KMT2B

1.06e-042819227256596
Pubmed

Impact of WIN site inhibitor on the WDR5 interactome.

KMT2A KMT2B

2.52e-044319233472061
Pubmed

Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo.

KMT2A KMT2B

2.64e-044419224183668
Pubmed

Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.

KMT2A KMT2B

3.27e-044919234368113
Pubmed

SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.

FHL3 KMT2A KMT2B

3.30e-0425119331076518
Pubmed

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.

KMT2A KMT2B

3.41e-045019237974198
Pubmed

New nomenclature for chromatin-modifying enzymes.

KMT2A KMT2B

4.43e-045719218022353
Pubmed

A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.

KMT2A KMT2B

5.08e-046119220305087
InteractionATN1 interactions

MEGF6 KMT2A FBLN1 KMT2B

2.50e-05187194int:ATN1
Cytoband12q22

FGD6 EEA1

1.32e-044119212q22
Cytoband19q13.1

RASGRP4 KMT2B

2.38e-045519219q13.1
CytobandEnsembl 112 genes in cytogenetic band chr12q22

FGD6 EEA1

2.55e-0457192chr12q22
GeneFamilyZinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors

MTMR3 ZFYVE28 FGD6 FGD5 MTMR4 WDFY3 EEA1 ZFYVE21

6.71e-193117881
GeneFamilyZinc fingers CXXC-type

KMT2A KMT2B

5.46e-0512172136
GeneFamilyMyotubularins|Phosphoinositide phosphatases

MTMR3 MTMR4

8.67e-0515172903
GeneFamilyPhosphoinositide phosphatases

MTMR3 MTMR4

4.06e-04321721079
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

KMT2A KMT2B

4.59e-0434172487
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

FGD6 FGD5

1.72e-0366172722
GeneFamilyPHD finger proteins

KMT2A KMT2B

3.17e-039017288
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

FGD6 FGD5

1.57e-02206172682
CoexpressionAtlasMyeloid Cells, DC.8+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-2

FGD6 RASGRP4 BTLA MTMR4 RUBCNL WDFY3

1.05e-06407196GSM538258_500
CoexpressionAtlasMyeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2

FGD6 RASGRP4 BTLA MTMR4 RUBCNL WDFY3

1.08e-06409196GSM538234_500
CoexpressionAtlasMyeloid Cells, DC.8+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2

FGD6 RASGRP4 BTLA MTMR4 RUBCNL WDFY3

1.13e-06412196GSM538260_500
CoexpressionAtlasMyeloid Cells, DC.8+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3

FGD6 RASGRP4 BTLA MTMR4 RUBCNL WDFY3

1.26e-06420196GSM538252_500
CoexpressionAtlasMyeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3

FGD6 RASGRP4 BTLA MTMR4 RUBCNL WDFY3

1.35e-06425196GSM538255_500
CoexpressionAtlasMyeloid Cells, DC.103+11b-.SI, CD45+ MHCII+ CD11c-hi CD103+ CD11b-, Small Intestine, avg-4

RASGRP4 BTLA MTMR4 RUBCNL WDFY3

1.53e-05372195GSM854251_500
CoexpressionAtlasMyeloid Cells, DC.103+11b-.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD103+ CD11b-, Small Intestine, avg-5

RASGRP4 BTLA MTMR4 RUBCNL WDFY3

1.69e-05380195GSM854246_500
CoexpressionAtlasMyeloid Cells, DC.8+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1

FGD6 RASGRP4 BTLA RUBCNL WDFY3

2.09e-05397195GSM605827_500
CoexpressionAtlasMyeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3

RASGRP4 BTLA RUBCNL WDFY3

3.29e-04384194GSM605820_500
CoexpressionAtlasMyeloid Cells, DC.103+11b-.Lu, MHCII+ CD11c+ CD103+ CD11b, Lung, avg-2

RASGRP4 BTLA RUBCNL WDFY3

3.92e-04402194GSM854241_500
CoexpressionAtlasMyeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3

RASGRP4 BTLA RUBCNL WDFY3

4.06e-04406194GSM854273_500
CoexpressionAtlasMyeloid Cells, DC.8+.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3

RASGRP4 BTLA MTMR4 RUBCNL

4.30e-04412194GSM605828_500
CoexpressionAtlasMyeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1

RASGRP4 BTLA MTMR4 RUBCNL

4.30e-04412194GSM605839_500
CoexpressionAtlasMyeloid Cells, DC.8-.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3

RASGRP4 BTLA MTMR4 RUBCNL

4.34e-04413194GSM605831_500
CoexpressionAtlasMyeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3

RASGRP4 BTLA RUBCNL WDFY3

4.79e-04424194GSM538231_500
CoexpressionAtlasB cells, B.Fo.MLN, CD19+ CD45R+ CD23+ CD21/35+, Lymph Node, avg-3

BTLA RUBCNL

1.02e-0353192GSM777021_100
CoexpressionAtlasB cells, B.T2.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3

BTLA RUBCNL

1.06e-0354192GSM538216_100
CoexpressionAtlasB cells, B.Fo.LN, CD19+ CD45R+ CD23+ CD21/35+, Lymph Node, avg-2

BTLA RUBCNL

1.06e-0354192GSM777019_100
CoexpressionAtlasCD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6

BTLA RUBCNL

1.06e-0354192GSM403988_100
CoexpressionAtlasB cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3

BTLA RUBCNL

1.10e-0355192GSM538201_100
CoexpressionAtlasB cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3

BTLA RUBCNL

1.13e-0356192GSM538219_100
CoexpressionAtlasB cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3

BTLA RUBCNL

1.22e-0358192GSM399440_100
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000

SYT8 ZFYVE28 FGD6 MTMR4 WDFY3

1.46e-03989195Facebase_RNAseq_e10.5_Maxillary Arch_1000
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32

MEGF6 SYT8 RASGRP4

1.07e-051021932c3622fc3cd62d9b7e185d0204cf7f03e7dde73c
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FGD6 ASB11 RUBCNL

3.52e-05152193b6a7453fbf9f898e4f222b215907c9a110baa2f6
ToppCelldroplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 BTLA RUBCNL

4.18e-051611937e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab
ToppCellPND07-Immune-Immune_Myeloid-DC-cDC1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASGRP4 BTLA MTMR4

4.41e-05164193662f74ad2656c0af158dbf9eb81d5bf70f54e529
ToppCelldroplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 RUBCNL WDFY3

5.00e-05171193e852d0e8589eecf4a2e5fea039b52a67c5d58dbd
ToppCellBAL-Control-cDC_11|Control / Compartment, Disease Groups and Clusters

FGD6 BTLA RUBCNL

5.35e-05175193daf014e15a354956e9149c83fd89d0af0d07eb00
ToppCellPBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters

FGD6 BTLA RUBCNL

5.54e-05177193974305e4c0eff90134c4e58cf11b955d1eee0501
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9

MTMR3 KMT2A WDFY3

5.54e-05177193e8ab340b20cd41554c3841fe980e078e878af35f
ToppCellwk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

MTMR3 SYT8 WDFY3

5.63e-05178193a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCellnormal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

BTLA FGD5 RUBCNL

5.82e-05180193a0b35067b6f2dbd8145da8bab760e9f650f045b0
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue

FGD6 BTLA RUBCNL

6.21e-05184193ee295f6fa898da53883e1358b17f2c2dd177e9a7
ToppCelldroplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MEGF6 SYT8 ZFYVE28

6.42e-0518619329c79b5a29907d4f3f87ad2ca04840c0f15b7d4e
ToppCelldroplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MEGF6 SYT8 FGD5

6.52e-05187193e93cad16a087d1443cbf4e1690dc1b35d7a84c41
ToppCellcontrol-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

BTLA RUBCNL

1.37e-031301929fe3c5be8488d341cff38757daf7856c112410d0
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

MEGF6 FBLN1

1.39e-031311929ca209a8652aae603c4a867ea06b06ac51e7d189
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BTLA RUBCNL

1.39e-03131192a3a086ce6e69707ca6a042f3b15c130f81909acb
ToppCellE18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E18.5-samps / Age Group, Lineage, Cell class and subclass

ASB11 BTLA

1.46e-03134192a4b9163af68e92d047b0005fd2f98aa63846b65b
ToppCellPND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass

SYT8 FBLN1

1.48e-031351925b13ff740d9f7d96274aebb6b389a80f6004adc7
ToppCellsevere-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

BTLA RUBCNL

1.50e-0313619256a7b5c2e098b4a49124d1b905257a52eb38b519
ToppCellURO-Lymphocyte-T_NK-CD8_TCM|URO / Disease, Lineage and Cell Type

ASB11 FGD5

1.61e-0314119253aef819f505238011f8a3202445f31055791d05
ToppCelldroplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHL3 RASGRP4

1.63e-03142192bf4a9633d128805a0d7e426d6fe6c29db1ff8c81
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ASB11 RUBCNL

1.70e-031451928abbc781f5f69f039617c29a5589d7b6950c2c40
ToppCellHealthy-B_cell|World / disease group, cell group and cell class

BTLA RUBCNL

1.72e-03146192588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f
ToppCelldroplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHL3 RASGRP4

1.75e-03147192c031fad0a4e192019775809968e46da54a111d27
ToppCelldroplet-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHL3 RASGRP4

1.75e-03147192684e2d8d2f0516cf8b0dc53efa7efc3050bbf0d1
ToppCell10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue

RASGRP4 WDFY3

1.77e-03148192de35eeefad0e27a0d127e2e4bedead2bddb75152
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-3|TCGA-Stomach / Sample_Type by Project: Shred V9

RASGRP4 FGD5

1.77e-03148192c95a732163050cfb5d604c2a4c9eb1afa9f19a95
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FGD6 RUBCNL

1.80e-031491928638b3819193d11411df58964069fec583f617f4
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

BTLA RUBCNL

1.84e-031511920f8f07e44c6edaf09574930b416fdce14d67095a
ToppCellBasal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

SYT8 FBLN1

1.87e-0315219272499e4d2b374ef5f1621c89d94727ecf4bd4d5d
ToppCellHealthy-B_cell|Healthy / disease group, cell group and cell class

BTLA RUBCNL

1.89e-031531927f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

BTLA RUBCNL

1.94e-03155192d336559092563b0d7776eef873f1d2759aca45f7
ToppCellE18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BTLA RUBCNL

1.97e-0315619244ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1
ToppCellE18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BTLA RUBCNL

1.97e-0315619255ba43cec9d79f309e9f633a6469cf03bb621e64
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MEGF6 BTLA

1.97e-031561927ece590fd8f29382e349dd0e5e016d2926aeb518
ToppCellfacs-Lung-EPCAM-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYT8 RASGRP4

1.99e-03157192d2cb261a9ee2c90e2e0fc656bd6413fbccb465fc
ToppCellfacs-Lung-EPCAM-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYT8 RASGRP4

1.99e-03157192350069e4d2dbddc82e813e2a2cc43032daa23605
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ASB11 RUBCNL

1.99e-031571925aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZFYVE28 FGD6

1.99e-031571921f21d78a467fe22c5ab75d0917b840c1ac93f32c
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BTLA RUBCNL

2.01e-0315819278a8a498a9c84ed65e0eefaac781d5247c5b477a
ToppCell368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells)

BTLA RUBCNL

2.01e-03158192c276a259e20ee704e2d04baf693e8d677f96f654
ToppCellCOPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class

FHL3 FGD6

2.01e-031581928f66979e92f886d86cecbd26aaa0c5915c049734
ToppCell10x5'v1-week_14-16-Myeloid_DC-DC-DC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

FBLN1 BTLA

2.01e-031581925d8a345df1d3001f34740b9f2f5f92f5428bbee6
ToppCellmetastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

MEGF6 SYT8

2.01e-03158192ab05f6d7968ccd6d3826cd71b763dbedc83822c3
ToppCellSevere-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

BTLA RUBCNL

2.04e-031591922881b054bbeb479221ee3c38bbd9b0815b123579
ToppCellAdult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor

ASB11 FBLN1

2.04e-031591923f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZFYVE28 FBLN1

2.04e-031591927ed659163f45e0c4df4782997c0786900c8186c8
ToppCellPND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASGRP4 BTLA

2.04e-03159192a5fee9e7ee00c20a4ba30b0dfaf1189fb109a1af
ToppCellfacs-Lung-EPCAM-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHL3 RASGRP4

2.07e-03160192b73f07a0088936fbc3656a05710a67f38b4ae551
ToppCellCOVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

FBLN1 RUBCNL

2.07e-0316019261f4cb4eb4313d8318aadbb99595a6cb7fd919f7
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BTLA RUBCNL

2.07e-031601928396afbc7d919ba190863d50aa0ef8b9942a9866
ToppCellfacs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BTLA RUBCNL

2.07e-031601925c9281706009558c8361bfa76169f43ffc0f7947
ToppCellCOVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

FBLN1 RUBCNL

2.07e-0316019234b4f710cfcb6ec370b8b074f3cbfe272f392cec
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BTLA RUBCNL

2.07e-03160192cfd005e98944817458e8ef9e0c436d77f50c1ad1
ToppCellfacs-Lung-EPCAM-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHL3 RASGRP4

2.07e-03160192b88876a58fea2066468e74dcc439c8561130a910
ToppCellICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, Lineage and Cell Type

TRIM45 BTLA

2.09e-031611929fb73909fc2ec99f96ca2eed1a053bce89de7d16
ToppCell368C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

BTLA RUBCNL

2.09e-031611921011094c54381d52566e24c92f89f2efc2aa3eea
ToppCellfacs-Lung-24m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SYT8 BTLA

2.12e-031621924e418bea07e35038b32a78a1e6632b6ec1208cdc
ToppCelldroplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 FBLN1

2.12e-0316219271d7849108a1b59beff40e46000172c45a2f5439
ToppCellnormal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

BTLA RUBCNL

2.12e-03162192ae292318d339305932457bb0e91430594f7a3dfa
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BTLA RUBCNL

2.12e-03162192b46158e260bd2f35702cec73e3b035e8e9ec4469
ToppCellChildren_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

BTLA RUBCNL

2.12e-0316219286a0b9dabd150dc993bfc0f3344804de7f8e4042
ToppCell5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BTLA RUBCNL

2.12e-03162192448602d5ff8b5be9614c63540a4d0fe6bdaf23b4
ToppCellE18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass

FGD5 RUBCNL

2.14e-03163192d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b
ToppCellImmune_cells-B_cell|World / Lineage and Cell class

BTLA RUBCNL

2.14e-031631923a02465de7c2f7cea227e289fb082a1fb6400301
ToppCell368C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

BTLA RUBCNL

2.14e-03163192299ac2463b7f58eee419d822a2a2d64b973d87e9
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

FBLN1 FGD5

2.14e-03163192c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e
ToppCellfacs-Trachea-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BTLA RUBCNL

2.17e-031641924274a4f225cabf61f0fe27d8ea162b4eba612f87
ToppCellfacs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 RUBCNL

2.17e-0316419215d52666e5150e7c34b1f641a937fb2d5e8aaf8a
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BTLA RUBCNL

2.17e-0316419243045879505774ac0d9b7f760557955564f06d00
ToppCellfacs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BTLA RUBCNL

2.17e-03164192d62143450f59097ad4b34603a6257f897a769ead
ToppCellfacs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 RUBCNL

2.17e-03164192d622f0d8d8bad48dfdf160ec63c545df192637a9
ToppCellBasal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

SYT8 FBLN1

2.17e-0316419285487a303194f5244956ec1ca2d1758d38117f41
ToppCellfacs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BTLA RUBCNL

2.17e-031641925ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce
ToppCellfacs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MEGF6 FBLN1

2.17e-031641927a65c7a6dbe5fb9067f83efafbb7ec8206d79325
ToppCellfacs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BTLA RUBCNL

2.17e-0316419207d9252b267cb61c6050fbfa5b440aef1349f673
ToppCelldroplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 BTLA

2.17e-03164192a67dd181eba275c191f4d0cab13df30eaa3ad913
ToppCellfacs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MTMR3 KMT2B

2.17e-031641921d0d88132baaa3154c3e6e4ef0aff795afab08a2
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ZFYVE28 BTLA

2.17e-0316419230c3c25b05a403a509b2e755c2f0878fecb10a02
ToppCellfacs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BTLA RUBCNL

2.17e-031641927c016236f0cea38195c1373ebbd2c0b2b2ec81ad
ToppCellfacs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MTMR3 KMT2B

2.17e-03164192bd2e10b015d5e6a338675500ec5d81dc39583b3e
ToppCellBAL-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters

BTLA RUBCNL

2.17e-031641924bd9629d054545d1e3f9e5c127b5ac2388637106
ToppCellCerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32

MEGF6 FGD5

2.19e-031651927d319a112b9062efee428bef6f4534d2ce782e04
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BTLA RUBCNL

2.19e-03165192fead3f2032f8fa5f7f0159a4434989b3d65debbb
ToppCell10x5'-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue

BTLA RUBCNL

2.19e-031651921776e7db80d7cf6b449fa8635a111705a59231b4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

BTLA RUBCNL

2.19e-0316519283095377aedf960c05baa523869bdbd2b0a05f2d
ToppCelldroplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHL3 TRIM45

2.19e-03165192354978d4f35154d7b2e36e94de669e045adef512
ToppCelldroplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZFYVE28 RASGRP4

2.22e-03166192de319c960b0cd90b294f677d1ea1b013a2ce2d53
ToppCellTCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9

RASGRP4 FGD5

2.22e-03166192a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f
ToppCellTCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9

RASGRP4 FGD5

2.22e-03166192c64971c27cb445dffc5a636d4b6a60261b93a2db
ToppCelldroplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 BTLA

2.22e-03166192e01c720de6d4ca144c55378e023e718a64bf32f6
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BTLA RUBCNL

2.22e-03166192a8ba4d51e778634f8a7f47fa0d01a2019f774fb8
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

BTLA KMT2B

2.22e-03166192c8a7d94ed762e5e045ab5f74eef691ddc5f74993
ToppCellTCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9

RASGRP4 FGD5

2.22e-03166192188f2575511f418216874aed9118aa6f165252cb
ToppCellnormal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

BTLA RUBCNL

2.22e-031661926210a136efb99d70c2026b6454363f1bd2723558
ToppCellBasal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

SYT8 FBLN1

2.22e-0316619223c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BTLA RUBCNL

2.22e-031661924906c85f52c3751166e296102d524a13b1f438f5
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BTLA RUBCNL

2.22e-0316619204e32bd32165cdf316f2a8709c3662d55cd70391
ToppCelldroplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBLN1 MTMR4

2.22e-031661929adceb746e67e955fd8b3e0984f4eed44b64a270
ToppCellTCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9

RASGRP4 FGD5

2.22e-031661922f3072a7af048f184d33065fdd36153fd563155a
ComputationalNeighborhood of MLL

MTMR3 KMT2A MTMR4

6.25e-04174113GCM_MLL
DrugPtdIns(3)P

MTMR3 MTMR4 WDFY3 EEA1

1.19e-05175194CID000643964
DrugAC1OAGFW

MTMR3 MTMR4 WDFY3 EEA1

1.46e-05184194CID006857352
DrugVancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A

MTMR3 MEGF6 FBLN1 WDFY3

1.87e-051961944423_DN
DrugCHEMBL35507

MTMR3 MTMR4

2.46e-0428192CID013671153
Drug1y6r

MTMR3 KMT2A

3.86e-0435192CID000446609
Drug16, 16-dimethylprostaglandin E2 methyl acetate solution; Up 200; 10uM; PC3; HT_HG-U133A

TRIM45 FBLN1 WDFY3

4.87e-041881936562_UP
DrugImipramine hydrochloride [113-52-0]; Up 200; 12.6uM; PC3; HT_HG-U133A

FGD6 EEA1 KMT2B

4.95e-041891931807_UP
DrugLidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A

MEGF6 KMT2A FBLN1

5.02e-041901934421_DN
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

FGD6 WDFY3 EEA1

5.10e-041911934303_DN
DrugDeltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A

MTMR3 KMT2A FBLN1

5.18e-041921933925_DN
DrugAcetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A

MEGF6 KMT2A KMT2B

5.18e-041921931829_UP
Drugalpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA

MTMR3 TRIM45 MTMR4

5.26e-041931931048_DN
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A

FHL3 FBLN1 KMT2B

5.26e-041931934322_UP
DrugPiperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A

MTMR3 MEGF6 KMT2A

5.26e-041931933845_UP
Drugoxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA

KMT2A FBLN1 WDFY3

5.26e-04193193971_UP
DrugBetazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A

FGD6 WDFY3 KMT2B

5.34e-041941931812_UP
DrugFlutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A

MEGF6 KMT2A FBLN1

5.34e-041941933885_UP
DrugDizocilpine maleate [77086-22-7]; Up 200; 11.8uM; PC3; HT_HG-U133A

FBLN1 WDFY3 EEA1

5.34e-041941932069_UP
DrugMoxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A

FBLN1 WDFY3 KMT2B

5.34e-041941934648_DN
DrugSolanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A

TRIM45 KMT2A WDFY3

5.42e-041951932808_DN
DrugBumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A

TRIM45 FBLN1 KMT2B

5.42e-041951935117_DN
Drugwortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A

MTMR3 FHL3 WDFY3

5.42e-041951931184_UP
Drugprochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A

FHL3 WDFY3 ZFYVE21

5.42e-041951931156_UP
DrugCefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A

KMT2A FBLN1 EEA1

5.42e-041951936159_DN
DrugRescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A

MEGF6 FBLN1 WDFY3

5.42e-041951934386_DN
DrugEvoxine [522-11-2]; Down 200; 11.6uM; HL60; HT_HG-U133A

FHL3 FBLN1 WDFY3

5.50e-041961932186_DN
DrugQuinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A

FHL3 KMT2A FBLN1

5.50e-041961932978_DN
DrugOzagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; HL60; HT_HG-U133A

MTMR3 FBLN1 EEA1

5.50e-041961932942_DN
DrugIsoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A

FBLN1 KMT2B ZFYVE21

5.50e-041961935812_DN
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

MTMR3 WDFY3 EEA1

5.50e-041961931054_DN
DrugBudesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

TRIM45 FBLN1 WDFY3

5.50e-041961936330_DN
DrugPerphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A

FBLN1 WDFY3 EEA1

5.58e-041971931540_DN
DrugAustricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A

KMT2A MTMR4 KMT2B

5.58e-041971932812_DN
DrugYohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; PC3; HT_HG-U133A

FGD6 FBLN1 KMT2B

5.58e-041971937130_DN
DrugMephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A

TRIM45 FGD6 EEA1

5.58e-041971933425_DN
DrugSulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A

MTMR3 TRIM45 RUBCNL

5.58e-041971933769_UP
DrugTetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A

KMT2A FGD6 WDFY3

5.58e-041971933338_DN
Drug2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A

TRIM45 WDFY3 KMT2B

5.58e-041971936941_DN
Drug0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A

FBLN1 WDFY3 KMT2B

5.58e-041971937069_UP
DrugVincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A

FBLN1 WDFY3 EEA1

5.58e-041971932327_DN
Drugaspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A

TRIM45 KMT2A FBLN1

5.58e-041971932664_UP
Drugnordihydroguaiaretic acid; Up 200; 1uM; ssMCF7; HG-U133A

MTMR3 FGD6 EEA1

5.58e-04197193415_UP
DrugHeptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A

TRIM45 FBLN1 ZFYVE21

5.58e-041971931825_UP
DrugSulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A

FBLN1 WDFY3 EEA1

5.58e-041971935098_DN
Drugprostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A

FGD6 FBLN1 EEA1

5.66e-041981936552_UP
DrugCarbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

MTMR3 MEGF6 FBLN1

5.66e-041981936786_UP
DrugAmidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A

FBLN1 WDFY3 EEA1

5.66e-041981932060_UP
DrugGuanabenz acetate [23256-50-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A

FGD6 FBLN1 WDFY3

5.66e-041981931544_DN
DrugCaffeic acid [3331-39-5]; Down 200; 22.2uM; MCF7; HT_HG-U133A

FGD6 EEA1 KMT2B

5.66e-041981935352_DN
DrugBisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A

MTMR3 MEGF6 RUBCNL

5.66e-041981936748_UP
DrugParoxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A

MTMR3 RUBCNL WDFY3

5.66e-041981934378_UP
DrugFoliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A

MTMR3 FHL3 RUBCNL

5.75e-041991934295_UP
DrugGlimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A

MEGF6 KMT2A FBLN1

5.75e-041991934973_UP
DrugMetanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A

TRIM45 KMT2A WDFY3

5.75e-041991931933_DN
DrugMeclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A

MTMR3 FBLN1 WDFY3

5.75e-041991934982_UP
DrugTolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A

MTMR3 MEGF6 KMT2A

5.75e-041991932320_UP
DrugRoxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A

FBLN1 RUBCNL KMT2B

5.75e-041991934778_UP
DrugXylazine [7361-61-7]; Down 200; 18.2uM; HL60; HT_HG-U133A

FHL3 FBLN1 WDFY3

5.75e-041991932132_DN
DrugAcenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A

WDFY3 EEA1 ZFYVE21

5.83e-042001932077_UP
DrugLevocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; HL60; HT_HG-U133A

FHL3 WDFY3 EEA1

5.83e-042001932948_DN
DrugMidecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A

MEGF6 FBLN1 KMT2B

5.83e-042001931526_UP
DrugDiloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A

KMT2A FBLN1 KMT2B

5.83e-042001936679_DN
DrugMyricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A

MTMR3 FHL3 KMT2A

5.83e-042001934170_UP
Diseasecentronuclear myopathy X-linked (implicated_via_orthology)

MTMR3 MTMR4

1.41e-059192DOID:0111225 (implicated_via_orthology)
DiseaseCharcot-Marie-Tooth disease (implicated_via_orthology)

MTMR3 MTMR4

1.08e-0424192DOID:10595 (implicated_via_orthology)
Diseasecongenital heart disease (implicated_via_orthology)

KMT2A KMT2B

8.98e-0469192DOID:1682 (implicated_via_orthology)
DiseaseNeurodevelopmental Disorders

KMT2A WDFY3

1.62e-0393192C1535926
DiseaseMalignant mesothelioma

FGD6 MTMR4

2.22e-03109192C0345967
Diseasebrain aneurysm

MTMR3 FGD6

2.38e-03113192EFO_0003870
Diseasehematocrit

MTMR3 FBLN1 FGD5 ZFYVE21

3.52e-031011194EFO_0004348
Diseaseascending aortic diameter

FHL3 FGD5

3.63e-03140192EFO_0021787
Diseaseprostate cancer (is_marker_for)

KMT2A KMT2B

4.48e-03156192DOID:10283 (is_marker_for)
DiseaseFEV/FEC ratio

MTMR3 MEGF6 FGD6 FBLN1

7.01e-031228194EFO_0004713
Diseasechronic obstructive pulmonary disease

MTMR3 MEGF6 FGD6

9.26e-03688193EFO_0000341
Diseaseeosinophil percentage of leukocytes

RASGRP4 BTLA KMT2B

1.15e-02746193EFO_0007991

Protein segments in the cluster

PeptideGeneStartEntry
CFCLFCCLRRHQGKQ

BTLA

171

Q7Z6A9
CRLCVRKCLGRACHQ

ASB11

291

Q8WXH4
CRRCSACRACFHKQC

RUBCNL

621

Q9H714
KHHCRSCGKIFCSRC

ZFYVE28

836

Q9HCC9
RHHCHACGKIVCRNC

FGD5

1261

Q6ZNL6
CRECGLCCHKHCRDQ

RASGRP4

571

Q8TDF6
CRRCKFCHVCGRKGR

KMT2B

1246

Q9UMN6
KRRHHCRNCGNVFCA

MTMR4

1131

Q9NYA4
VKRCCHCCLLGRAAQ

FBLN1

106

P23142
RHHCRQCGNIFCAEC

EEA1

1371

Q15075
FHEGCFRCCRCQRSL

FHL3

61

Q13643
CRRCKFCHVCGRQHQ

KMT2A

1476

Q03164
SRKHHCRNCGNVFCS

MTMR3

1136

Q13615
HCRKKCNCANRGRCH

MEGF6

606

O75095
LLCAACCCCRRHRKK

SYT8

66

Q8NBV8
KANLCHFCCQAHRRQ

TRIM45

151

Q9H8W5
ERRHHCRNCGQLFCQ

WDFY3

3471

Q8IZQ1
RHHCRACGKIVCQAC

FGD6

1241

Q6ZV73
TRKHHCRRCGKCFCD

ZFYVE21

61

Q9BQ24